Customization: | Available |
---|---|
CAS No.: | 35212-22-7 |
Formula: | C18h16o3 |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Name | Ipriflavone |
Synonyms | 7-Isoproxyisoflavone; Yambolap; Osteofix; 7-(1-Methylethoxy)-3-phenyl-4H-1-benzopyron-4-one |
Molecular Structure | |
Molecular Formula | C18H16O3 |
Molecular Weight | 280.32 |
CAS Registry Number | 35212-22-7 |
Melting point | 114-118 ºC |
---|---|
CERTIFICATE OF ANALYSIS | ||||||
Product name | Ipriflavone | Country of Origin | China | |||
Quantity | 300KGS | Batch Number | SUREST20250224 | |||
Manufacture Date | Feb.24th,2025 | Expiry Date | Feb.23th,2027 | |||
Report Date | Feb.26th,2025 | Analytical Method | Enterprise Standard | |||
Items | Specification | Results | Method | |||
Characteristics | White crystalline powder | Conforms | Organoleptic | |||
Odor | odorless | Conforms | Organoleptic | |||
Identification | IR spectrum | Conforms | IR | |||
Assay(HPLC) | 98.0%min | 99.6% | HPLC | |||
Loss on drying(%) | ≤0.5% | 0.06% | CP2020 | |||
Melting point | 116-120ºC | 116.5-117.5ºC | CP2020 | |||
Heavy Metal | 10ppm maximum | Conforms | ICP/MS | |||
Arsenic | 1ppm maximum | Conforms | ICP/MS | |||
Lead | 1ppm maximum | Conforms | ICP/MS | |||
Cadmium | 0.3ppm maximum | Conforms | ICP/MS | |||
Mercury | 0.2ppm maximum | Conforms | ICP/MS | |||
Residue on ignition | ≤0.5% | 0.05% | CP2020 | |||
Microbiological Items | ||||||
Total Plate Count | NMT1000cfu/g | Conforms | CP2020 | |||
Yeast & Mold | NMT100cfu/g | Conforms | CP2020 | |||
E.coli | Negative | Conforms | CP2020 | |||
Salmonella | Negative | Conforms | CP2020 | |||
Staphylococcus Aureus | Negative | Conforms | CP2020 | |||
Conclusion | Qualified. |
The use of Yipu flavonoids
Treatment of bone metabolism disorders
1. Improving osteoporosis: Used to treat primary osteoporosis, increase bone density, and alleviate symptoms of bone loss.
Adjuvant therapy for cardiovascular system diseases
1. Vascular dilation and blood pressure regulation: By relaxing smooth muscle cells to reduce peripheral vascular resistance, dilate blood vessels, and assist in regulating blood pressure.
2. Inhibit platelet aggregation: reduce platelet activation and adhesion, lower the risk of thrombosis, and improve blood circulation.
3. Improve microcirculation: promote capillary blood flow, enhance red blood cell deformability, and reduce blood viscosity.
Antioxidant and anti-inflammatory effects
1. Clearing free radicals: combating oxidative stress damage and protecting cells from oxidative damage.
2. Inhibit inflammatory response: reduce the synthesis of inflammatory mediators (such as prostaglandin E2) and alleviate tissue inflammation.
Other clinical applications
1. Relieve menopausal symptoms: By regulating estrogen receptor expression, indirectly improve menopausal symptoms such as hot flashes and night sweats.
2. Anti allergic effect: Block histamine H1 receptors and alleviate allergic reactions (such as itching and redness).
3. Potential lipid-lowering effect: Increases high-density lipoprotein cholesterol (HDL-C) and reduces low-density lipoprotein cholesterol (LDL-C) levels.
FAQ